# Pre-Prostatectomy Lovastatin on Prostate Cancer

> **NCT01478828** · NA · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 2 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Lovastatin

## Key facts

- **NCT ID:** NCT01478828
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07-13
- **Primary completion:** 2013-04-08
- **Final completion:** 2013-04-08
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study was stopped due to an unanticipated serious adverse event.
- **Last updated:** 2019-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01478828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01478828, "Pre-Prostatectomy Lovastatin on Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01478828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*